Asia Pac Allergy.  2016 Oct;6(4):220-225. 10.5415/apallergy.2016.6.4.220.

Pale nasal mucosa affects airflow limitations in upper and lower airways in asthmatic children

• Motomura C
• Odajima H
• Yamada A
• Taba N
• Murakami Y
• Nishima S

• KMID: 2397018
• DOI: http://doi.org/10.5415/apallergy.2016.6.4.220

Abstract

BACKGROUND
Severe asthmatics are thought to have severer rhinitis than mild asthmatics. A pale nasal mucosa is a typical clinical finding in subjects with severe allergic rhinitis.
OBJECTIVE
The aim of this study was to investigate whether a pale nasal mucosa affects airflow limitations in the upper and lower airways in asthmatic children.
METHODS
Rhinomanometry, nasal scraping, and spirometry were performed in 54 asthmatic children (median age, 10 years). The nasal mucosa was evaluated by an otolaryngologist. Thirty-seven patients were treated with inhaled corticosteroids, and 11 patients were treated with intranasal corticosteroids.
RESULTS
Subjects with a pale nasal mucosa (n = 23) exhibited a lower nasal airflow (p < 0.05) and a larger number of nasal eosinophils (p < 0.05) in the upper airway as well as lower pulmonary functional parameters (p < 0.05 for all comparisons), i.e., the forced vital capacity (FVC), the forced expiratory volume in 1 second, and the peak expiratory flow, compared with the subjects who exhibited a normal or pinkish mucosa (n = 31). No significant difference in the forced expiratory flow between 25%-75% of the FVC, regarded as indicating the peripheral airway, was observed between the 2 groups.
CONCLUSION
A pale nasal mucosa may be a predictor of eosinophil infiltration of the nasal mucosa and central airway limitations in asthmatic children. When allergists observe a pale nasal mucosa in asthmatic children, they should consider the possibility of airflow limitations in not only the upper airway, but also the lower airway.

Keyword

Rhinitis, allergic; Asthma; Eosinophils; Airflow limitation; Nasal obstruction

MeSH Terms

Adrenal Cortex Hormones
Asthma
Child*
Eosinophils
Forced Expiratory Volume
Humans
Mucous Membrane
Nasal Mucosa*
Nasal Obstruction
Rhinitis
Rhinitis, Allergic
Rhinomanometry
Spirometry
Vital Capacity
Adrenal Cortex Hormones

Reference

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group. World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001; 108:5 Suppl. S147–S334.

2. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999; 104(2 Pt 1):301–304.

3. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol. 1992; 148:2390–2394.

4. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000; 161:1720–1745.

5. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D. World Health Organization. GA(2)LEN. AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63:suppl 86. 8–160.

6. Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, Ryan D, Walker SM, Clark AT, Dixon TA, Jolles SR, Siddique N, Cullinan P, Howarth PH, Nasser SM. British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008; 38:19–42.

7. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy. 1994; 49:19 Suppl. 1–34.

8. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, Li JT, Bernstein IL, Berger W, Spector S, Schuller D. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998; 81(5 Pt 2):478–518.

9. Definition, pathophysiology and pathogenesis of asthma, and natural history of asthma. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Full Report 2007. Bethesda (MD): U.S. Department of health and human services; National Heart, Lung, and Blood Institute;2007. p. 12–27.

10. Nasal allergy practice guidelines making Committee. Practical guideline for the management of allergic rhinitis in Japan. Tokyo: Life Science;2009.

11. Howarth PH, Persson CG, Meltzer EO, Jacobson MR, Durham SR, Silkoff PE. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol. 2005; 115:3 Suppl 1. S414–S441.

12. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995; 152:1107–1136.

13. Nishima S. Flow-volume curve in healthy and asthmatic children. Rinsho To Kenkyu. 1977; 54:185–190.

14. Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, Aubier M. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy. 2006; 61:111–118.

15. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001; 107:469–476.

16. Dykewicz MS. 7. Rhinitis and sinusitis. J Allergy Clin Immunol. 2003; 111:2 Suppl. S520–S529.

17. Lemanske RF Jr, Busse WW. 6. Asthma. J Allergy Clin Immunol. 2003; 111:2 Suppl. S502–S519.

18. Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA. Correlation of nasal inflammation and nasal airflow with forced expiratory volume in 1 second in patients with perennial allergic rhinitis and asthma. Ann Allergy Asthma Immunol. 2004; 93:575–580.

19. Ciprandi G, Vizzaccaro A, Cirillo I, Tosca M, Massolo A, Passalacqua G. Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol. 2005; 136:266–272.

20. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002; 109:636–642.

21. Kessel A. The impact of intranasal corticosteroids on lung function in children with allergic rhinitis. Pediatr Pulmonol. 2014; 49:932–937.

22. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CC, Schuller D, Spector SL, Tilles SA. Joint Task Force on Practice. American Academy of Allergy. Asthma & Immunology. American College of Allergy. Asthma and Immunology. Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008; 122:2 Suppl. S1–S84.

23. Gaga M, Lambrou P, Papageorgiou N, Koulouris NG, Kosmas E, Fragakis S, Sofios C, Rasidakis A, Jordanoglou J. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy. 2000; 30:663–669.

24. Kim H, Levin L, LeMasters GK, Villareal M, Evans S, Lockey JE, Khurana Hershey GK, Bernstein DI. Validating childhood symptoms with physician-diagnosed allergic rhinitis. Ann Allergy Asthma Immunol. 2012; 108:228–231.

25. Masuda S, Fujisawa T, Katsumata H, Atsuta J, Iguchi K. High prevalence and young onset of allergic rhinitis in children with bronchial asthma. Pediatr Allergy Immunol. 2008; 19:517–522.

26. Joko H, Hyodo M, Gyo K, Yumoto E. Chromametric assessment of nasal mucosal color and its application in patients with nasal allergy. Am J Rhinol. 2002; 16:11–16.

27. Joko H, Hinohira Y, Yumoto E. Quantitative analysis of color of the nasal mucosa. Nihon Jibiinkoka Gakkai Kaiho. 1996; 99:594–600.